[et_pb_section bb_built=”1″ admin_label=”section”][et_pb_row admin_label=”row”][et_pb_column type=”4_4″][et_pb_text admin_label=”Text”]<\/p>\n
One of our very own\u00a0Dr. Goldenberg reviews the results from the report for\u00a0the #ELIXA\u00a0and #TECOS\u00a0trials \u2013 they were a focal point of interest at\u00a0American Diabetes Association<\/a>\u2018s #ADA75\u00a0this year in Boston.<\/p>\n See more footage of him responding to some key questions regarding the new data and safety in #diabetes:\u00a0http:\/\/bit.ly\/1eFNO3l<\/a><\/p>\n Read the report here:\u00a0http:\/\/bit.ly\/ada2015hl<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":" Uno dei nostri dottori Goldenberg esamina i risultati della relazione sugli studi #ELIXA e #TECOS, che sono stati al centro dell'interesse dell'American Diabetes Association #ADA75 di quest'anno a Boston.<\/p>","protected":false},"author":2,"featured_media":1464,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":" One of our very own\u00a0Dr. Goldenberg reviews the results from the report for\u00a0the #ELIXA\u00a0and #TECOS\u00a0trials \u2013 they were a focal point of interest at\u00a0American Diabetes Association<\/a>\u2018s #ADA75\u00a0this year in Boston.<\/p> See more footage of him responding to some key questions regarding the new data and safety in #diabetes:\u00a0http:\/\/bit.ly\/1eFNO3l<\/a><\/p>